• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

第 7 版 AJCC 分期分类对 NCCN 肿瘤学胃癌和食管癌临床实践指南的影响。

Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.

机构信息

Memorial Sloan-Kettering Cancer Center, New York, New York 10065, USA.

出版信息

J Natl Compr Canc Netw. 2013 Jan 1;11(1):60-6. doi: 10.6004/jnccn.2013.0009.

DOI:10.6004/jnccn.2013.0009
PMID:23307982
Abstract

The 7th edition of the AJCC Cancer Staging Manual has attempted to harmonize gastric and esophageal cancers, including management of gastroesophageal junction (GEJ)-type tumors. The treatment of complex tumor types is best guided by a staging classification that reliably groups patients according to prognosis and therapy. This article reviews and discusses these changes with the goal of elucidating key features of the staging system and outlining how these changes relate to the NCCN Clinical Practice Guidelines in Oncology with regard to the care and treatment of patients. The 7th edition of the AJCC Cancer Staging Manual has certainly improved harmonization of gastric and distal esophageal/GEJ-type adenocarcinomas, although issues persist, particularly regarding the optimal neoadjuvant treatment for the management of GEJ carcinomas.

摘要

《AJCC 癌症分期手册》第 7 版试图协调胃癌和食管癌,包括胃食管交界处(GEJ)型肿瘤的处理。对复杂肿瘤类型的治疗最好由分期分类来指导,该分类可根据预后和治疗可靠地对患者进行分组。本文旨在阐明分期系统的关键特征,并概述这些变化与 NCCN 肿瘤临床实践指南在患者护理和治疗方面的关系,以回顾和讨论这些变化。《AJCC 癌症分期手册》第 7 版确实提高了胃和远端食管/GEJ 型腺癌的协调性,尽管仍然存在一些问题,特别是关于 GEJ 癌管理的最佳新辅助治疗。

相似文献

1
Impact of the 7th Edition AJCC staging classification on the NCCN clinical practice guidelines in oncology for gastric and esophageal cancers.第 7 版 AJCC 分期分类对 NCCN 肿瘤学胃癌和食管癌临床实践指南的影响。
J Natl Compr Canc Netw. 2013 Jan 1;11(1):60-6. doi: 10.6004/jnccn.2013.0009.
2
A Multi-Institutional Study Comparing the Use of the American Joint Committee on Cancer 7th Edition Esophageal Gastric Staging System for Gastroesophageal Junction Cancer in a Western Population.一项多机构研究,比较美国癌症联合委员会第7版食管胃交界癌食管胃分期系统在西方人群中的应用情况。
Am Surg. 2017 Jan 1;83(1):82-89.
3
Staging of adenocarcinoma of the esophagogastric junction: comparison of AJCC 6th and 7th gastric and 7th esophageal staging systems.胃食管结合部腺癌分期:AJCC 第 6 版胃和第 7 版食管分期系统与第 7 版的比较。
Ann Surg Oncol. 2013 Aug;20(8):2713-20. doi: 10.1245/s10434-013-2898-5. Epub 2013 Mar 2.
4
[Evaluation of the value of 7th editions of UICC-AJCC esophageal and gastric cancer TNM staging systems for prognostic prediction of adenocarcinoma of esophagogastric junction (Siewert type II)].[UICC-AJCC第7版食管癌和胃癌TNM分期系统对食管胃交界腺癌(SiewertⅡ型)预后预测价值的评估]
Zhonghua Zhong Liu Za Zhi. 2014 Dec 23;36(12):916-21. doi: 10.3760/cma.j.issn.0253-3766.2014.12.008.
5
[Controversy on classification of cancers of the gastro-esophageal junction and its clinical significance].[胃食管交界部癌的分类争议及其临床意义]
Zhonghua Zhong Liu Za Zhi. 2006 Jan;28(1):76.
6
Comparison between gastric and esophageal classification system among adenocarcinomas of esophagogastric junction according to AJCC 8th edition: a retrospective observational study from two high-volume institutions in China.根据 AJCC 第 8 版,比较胃和食管分类系统在食管胃结合部腺癌中的应用:来自中国两家大容量机构的回顾性观察研究。
Gastric Cancer. 2019 May;22(3):506-517. doi: 10.1007/s10120-018-0890-2. Epub 2018 Nov 2.
7
Gastric cardiac carcinomas involving the esophagus are more adequately staged as gastric cancers by the 7th edition of the American Joint Commission on Cancer Staging System.涉及食管的胃贲门癌在第 7 版美国癌症联合委员会分期系统中被更恰当地归类为胃癌。
Mod Pathol. 2011 Jan;24(1):138-46. doi: 10.1038/modpathol.2010.183. Epub 2010 Sep 17.
8
Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer.食管癌与食管胃交界癌:第八版分期指南
J Thorac Oncol. 2017 Jan;12(1):36-42. doi: 10.1016/j.jtho.2016.10.016. Epub 2016 Oct 31.
9
[The new TNM classification of tumors of the esophagogastric junction. Surgical consequences].[食管胃交界部肿瘤的新TNM分类。手术后果]
Chirurg. 2012 Jan;83(1):23-30. doi: 10.1007/s00104-011-2146-0.
10
7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.《美国癌症联合委员会(AJCC)癌症分期手册》第7版:食管和食管胃交界部
Ann Surg Oncol. 2010 Jul;17(7):1721-4. doi: 10.1245/s10434-010-1024-1.

引用本文的文献

1
Therapeutic Effect of Lymph Node Dissection After Neoadjuvant Chemoradiation Therapy Followed by Esophagectomy on Esophageal Squamous Cell Carcinoma Using the Efficacy Index.新辅助放化疗后行淋巴结清扫并食管切除治疗食管鳞状细胞癌的疗效指数评估其治疗效果
Thorac Cancer. 2025 Mar;16(6):e70057. doi: 10.1111/1759-7714.70057.
2
Delta/pre-radiomics based on enhanced CT predicts complete response in locally advanced esophageal squamous cell carcinoma.基于增强CT的Delta/放射组学预测局部晚期食管鳞状细胞癌的完全缓解。
Am J Transl Res. 2025 Jan 15;17(1):162-177. doi: 10.62347/WQYO9624. eCollection 2025.
3
Impact of neoadjuvant FLOT treatment of advanced gastric and gastroesophageal junction cancer following surgical therapy.
新辅助FLOT治疗对晚期胃癌和胃食管交界癌手术治疗后的影响。
Front Surg. 2023 Apr 3;10:1148984. doi: 10.3389/fsurg.2023.1148984. eCollection 2023.
4
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.围手术期西妥昔单抗联合顺铂和5-氟尿嘧啶治疗食管胃腺癌:一项II期研究。
Cancers (Basel). 2023 Apr 6;15(7):2188. doi: 10.3390/cancers15072188.
5
Tumor regression grade combined with lymph node status in esophageal squamous cell carcinoma after neoadjuvant chemoradiotherapy.新辅助放化疗后食管鳞癌的肿瘤退缩分级与淋巴结状态。
Cancer Med. 2022 Oct;11(19):3623-3632. doi: 10.1002/cam4.4748. Epub 2022 Apr 17.
6
Comparison of the Efficacy of D2 Gastrectomy Plus Liver Radiofrequency Combined With Chemotherapy Versus Chemotherapy Alone in the Treatment of Advanced Gastric Cancer With Unresectable Synchronous Liver Metastases: A Multicenter Randomized Controlled Trial Protocol.D2胃切除术联合肝脏射频消融术与单纯化疗治疗不可切除的同步性肝转移晚期胃癌疗效比较:一项多中心随机对照试验方案
Front Oncol. 2022 Feb 28;12:802683. doi: 10.3389/fonc.2022.802683. eCollection 2022.
7
Circulating tumor DNA detection and its application status in gastric cancer: a narrative review.循环肿瘤DNA检测及其在胃癌中的应用现状:一篇叙述性综述
Transl Cancer Res. 2021 Jan;10(1):529-536. doi: 10.21037/tcr-20-2856.
8
Blood Free-Circulating DNA Testing of Methylated RUNX3 Is Useful for Diagnosing Early Gastric Cancer.甲基化RUNX3的血液游离循环DNA检测对早期胃癌诊断有帮助。
Cancers (Basel). 2020 Mar 26;12(4):789. doi: 10.3390/cancers12040789.
9
The Number of Negative Lymph Nodes is Positively Associated with Survival in Esophageal Squamous Cell Carcinoma Patients in China.在中国,食管鳞状细胞癌患者的阴性淋巴结数量与生存率呈正相关。
Open Med (Wars). 2020 Mar 8;15:152-159. doi: 10.1515/med-2020-0023. eCollection 2020.
10
S-1 plus docetaxel: a safe and effective chemotherapy regimen for stage III gastric cancer.S-1联合多西他赛:一种用于III期胃癌的安全有效的化疗方案。
Cancer Commun (Lond). 2019 Oct 26;39(1):65. doi: 10.1186/s40880-019-0408-2.